ADIM
CRNC icon

Alpha DNA Investment Management’s Cerence CRNC Stock Holding History

Alpha DNA Investment Management’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,262
Closed -$477K – 205
2023
Q4 		$477K Buy
+24,262
New +$421K 0.19% 136
2021
Q2 		– Sell
-17
Closed -$1K – 212
2021
Q1 		$1K Sell
17
-1
-6% -$110 ﹤0.01% 613
2020
Q4 		$1K Buy
+18
New +$1.34K ﹤0.01% 516

Other funds holding CRNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

Alpha DNA Investment Management's CRNC Position: Q1 2024 in Review

Alpha DNA Investment Management sold out of Cerence (CRNC) in Q1 2024, closing a stake of 24,262 shares — an estimated $477K sold.

Alpha DNA Investment Management first reported a position in CRNC in Q4 2020 and held it in 3 quarters. The position peaked at $477K in Q4 2023. 188 funds tracked by Wall St. Rank hold CRNC as of Q1 2024.

  • Alpha DNA Investment Management reported no remaining Cerence position as of Q1 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 24,262 Cerence shares in Q1 2024, an estimated $477K.
  • Alpha DNA Investment Management first reported a position in Cerence in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Cerence position peaked at $477K in Q4 2023.
  • 188 funds tracked by Wall St. Rank held Cerence as of Q1 2024.

Based on Alpha DNA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.